Keyphrases
Ovarian Tumor
100%
Patient Survival
100%
Tumor Tissue
100%
Tissue Analysis
100%
Cyclin E1
100%
Tubo-ovarian
100%
Ovarian High-grade Serous Carcinoma
100%
High-level Amplifications
60%
Overexpression
50%
Hazard Ratio
40%
High-grade Serous Carcinoma
40%
Overall Survival
30%
MRNA Expression
20%
Germ Cells
10%
Immunohistochemistry
10%
Non-associated
10%
Protein Level
10%
Therapeutic Target
10%
Inverse Association
10%
Pathogenic Variants
10%
BRCA1, BRCA2
10%
Prognostic Biomarker
10%
Predictive Marker
10%
Mutually Exclusive
10%
Multivariate Survival Analysis
10%
Chromogenic in Situ Hybridization
10%
Large-scale Validation
10%
Biochemistry, Genetics and Molecular Biology
Cyclin E1
100%
Overall Survival
30%
Messenger RNA
20%
Germline
10%
Germ Cell
10%
BRCA1
10%
Chromogenic In Situ Hybridization
10%
Immunology and Microbiology
Cycline
100%
Overall Survival
30%
Prognostic Biomarker
10%
Germ Cell
10%
In Situ Hybridization
10%